ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer

Annals of Oncology

Volumn 14, Issue 7, 2003, Pages 1006-1007

  Tveit, K M ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; EUROPEAN UNION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; PRIORITY JOURNAL; RECTOSCOPY; RECTUM CANCER; RISK ASSESSMENT; SALVAGE THERAPY;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; NEOPLASM STAGING; PRACTICE GUIDELINES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RISK ASSESSMENT;

EID: 0042703141     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg297     Document Type: Article

References (5)

1. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
2. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al. Preoperative radiotherapy in combination with total mesorectal excision improves local control in resectable rectal cancer. Report from a multicenter randomized trial. For the Dutch Colorectal Cancer Group and other cooperative investigators. N Engl J Med 2001; 345: 638-646.
3. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
4. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002; 1: CD002200.
5. Beets-Tan R, Beets G, Vliegen R et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.